...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Allergy >Drug allergy passport and other documentation for patients with drug hypersensitivity - An ENDA/EAACI Drug Allergy Interest Group Position Paper
【24h】

Drug allergy passport and other documentation for patients with drug hypersensitivity - An ENDA/EAACI Drug Allergy Interest Group Position Paper

机译：药物过敏患者的药物过敏护照和其他文件-ENDA / EAACI药物过敏兴趣小组立场文件

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

The strongest and best-documented risk factor for drug hypersensitivity (DH) is the history of a previous reaction. Accidental exposures to drugs may lead to severe or even fatal reactions in sensitized patients. Preventable prescription errors are common. They are often due to inadequate medical history or poor risk assessment of recurrence of drug reaction. Proper documentation is essential information for the doctor to make sound therapeutic decision. The European Network on Drug Allergy and Drug Allergy Interest Group of the European Academy of Allergy and Clinical Immunology have formed a task force and developed a drug allergy passport as well as general guidelines of drug allergy documentation. A drug allergy passport, a drug allergy alert card, a certificate, and a discharge letter after medical evaluation are adequate means to document DH in a patient. They are to be handed to the patient who is advised to carry the documentation at all times especially when away from home. A drug allergy passport should at least contain information on the culprit drug(s) including international nonproprietary name, clinical manifestations including severity, diagnostic measures, potential cross-reactivity, alternative drugs to prescribe, and where more detailed information can be obtained from the issuer. It should be given to patients only after full allergy workup. In the future, electronic prescription systems with alert functions will become more common and should include the same information as in paper-based documentation.
机译：药物超敏反应（DH）的最强和最有据可查的危险因素是先前反应的历史。意外接触药物可能导致致敏患者出现严重甚至致命的反应。可预防的处方错误很常见。它们通常是由于病史不足或药物反应复发的风险评估不佳所致。正确的文档记录对于医生做出正确的治疗决策至关重要。欧洲过敏和临床免疫科学院的欧洲药物过敏和药物过敏兴趣网络组已成立了一个工作队，并制定了药物过敏护照和药物过敏文献的一般指南。药物过敏护照，药物过敏警报卡，证明和医学评估后的出院信是记录患者体内DH的适当方法。应将其交给患者，建议患者随时携带文件，尤其是在出门时。药物过敏护照至少应包含有关罪魁祸首的信息，包括国际非专利名称，包括严重程度在内的临床表现，诊断措施，潜在的交叉反应性，处方药以及可以从发行人处获得更详细信息的信息。仅在完全过敏检查后才应给患者服用。将来，具有警报功能的电子处方系统将变得更加普遍，并且应包括与纸质文档相同的信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号